GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Bridge Biotherapeutics Inc (XKRX:288330) » Definitions » Accounts Payable

Bridge Biotherapeutics (XKRX:288330) Accounts Payable : ₩0.00 Mil (As of Sep. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Bridge Biotherapeutics Accounts Payable?

Bridge Biotherapeutics's Accounts Payable for the quarter that ended in Sep. 2024 was ₩0.00 Mil.


Bridge Biotherapeutics Accounts Payable Historical Data

The historical data trend for Bridge Biotherapeutics's Accounts Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Bridge Biotherapeutics Accounts Payable Chart

Bridge Biotherapeutics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Accounts Payable
Get a 7-Day Free Trial - - - - -

Bridge Biotherapeutics Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Accounts Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Bridge Biotherapeutics Accounts Payable Calculation

Accounts Payable represents any money that a company owes its suppliers for goods and services purchased on credit and is expected to pay within the next year or operating cycle.


Bridge Biotherapeutics Accounts Payable Related Terms

Thank you for viewing the detailed overview of Bridge Biotherapeutics's Accounts Payable provided by GuruFocus.com. Please click on the following links to see related term pages.


Bridge Biotherapeutics Business Description

Traded in Other Exchanges
N/A
Address
58, Pangyo - ro, Gyeonggi No. 303, 255 beongil Seas Tower in Bundang Pangyo, Seongnam-si, KOR, 13486
Bridge Biotherapeutics Inc is a drug research and development company. It operates in the pharmaceutical and bio industry. The company has two pipeline clinical-stage products namely, BBT-401 and BBT-877.

Bridge Biotherapeutics Headlines

No Headlines